INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

KENNEDY CAPITAL MANAGEMENT LLC's Holding History (CIK: 0000884589)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 5,822 Value ($000) $768 Avg Close — Range —
Q4 2024
Shares 5,747 Value ($000) $480 Avg Close — Range —
Q3 2024
Shares 4,682 Value ($000) $343 Avg Close — Range —
Q2 2024
Shares 3,574 Value ($000) $245 Avg Close — Range —
Q1 2024
Shares 19,321 Value ($000) $1,337 Avg Close — Range —
Q4 2023
Shares 27,367 Value ($000) $1,960 Avg Close — Range —
Q3 2023
Shares 29,817 Value ($000) $1,553 Avg Close — Range —
Q2 2023
Shares 69,734 Value ($000) $4,416 Avg Close — Range —
Q1 2023
Shares 108,354 Value ($000) $5,867 Avg Close — Range —
Q4 2022
Shares 308,646 Value ($000) $16,334 Avg Close — Range —
Q3 2022
Shares 323,609 Value ($000) $15,058 Avg Close — Range —
Q2 2022
Shares 253,319 Value ($000) $14,459 Avg Close — Range —
Q1 2022
Shares 241,255 Value ($000) $14,762 Avg Close — Range —
Q4 2021
Shares 204,822 Value ($000) $10,720 Avg Close — Range —
Q3 2021
Shares 98,356 Value ($000) $3,667 Avg Close — Range —